Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc van de Vijver

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
Current perspectives on HER2 testing: a review of national testing guidelinesMichael Bilous, Mitch Dowsett, Wedad Hanna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneityWedad M Hanna, Josef Rüschoff, Michael Bilous, et al.
Virchows Archiv : an International Journal of Pathology|March 29, 2018
Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimensEline Soer, Lodewijk Brosens, Marc van de Vijver, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast CancerJavier F Torres-Roca, William J Fulp, Jimmy J Caudell, et al.
Breast Cancer Research and Treatment|May 20, 2008
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902Johanna G H van Nes, Hein Putter, Jean-Pierre Julien, et al.
Cancer Research|May 19, 2005
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patientsHongyue Dai, Laura van't Veer, John Lamb, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
Radiation-associated breast tumors display a distinct gene expression profileAnnegien Broeks, Linde M Braaf, Lodewyk F A Wessels, et al.
Breast Cancer Research and Treatment|August 12, 2009
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseJorma J de Ronde, Juliane Hannemann, Hans Halfwerk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Lung metastasis genes couple breast tumor size and metastatic spreadAndy J Minn, Gaorav P Gupta, David Padua, et al.
Plos Biology|May 5, 2005
Determination of stromal signatures in breast carcinomaRobert B West, Dimitry S A Nuyten, Subbaya Subramanian, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
Current perspectives on HER2 testing: a review of national testing guidelinesMichael Bilous, Mitch Dowsett, Wedad Hanna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneityWedad M Hanna, Josef Rüschoff, Michael Bilous, et al.
Virchows Archiv : an International Journal of Pathology|March 29, 2018
Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimensEline Soer, Lodewijk Brosens, Marc van de Vijver, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast CancerJavier F Torres-Roca, William J Fulp, Jimmy J Caudell, et al.
Breast Cancer Research and Treatment|May 20, 2008
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902Johanna G H van Nes, Hein Putter, Jean-Pierre Julien, et al.
Cancer Research|May 19, 2005
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patientsHongyue Dai, Laura van't Veer, John Lamb, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
Radiation-associated breast tumors display a distinct gene expression profileAnnegien Broeks, Linde M Braaf, Lodewyk F A Wessels, et al.
Breast Cancer Research and Treatment|August 12, 2009
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseJorma J de Ronde, Juliane Hannemann, Hans Halfwerk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Lung metastasis genes couple breast tumor size and metastatic spreadAndy J Minn, Gaorav P Gupta, David Padua, et al.
Plos Biology|May 5, 2005
Determination of stromal signatures in breast carcinomaRobert B West, Dimitry S A Nuyten, Subbaya Subramanian, et al.
Pageof 3